APA (7th ed.) Citation

Amersfoort, J., Schaftenaar, F., Douna, H., van Santbrink, P., Kröner, M., van Puijvelde, G., . . . Bot, I. (2018). Lipocalin-2 contributes to experimental atherosclerosis in a stage-dependent manner. Atherosclerosis (00219150), 275, 214. https://doi.org/10.1016/j.atherosclerosis.2018.06.015

Chicago Style (17th ed.) Citation

Amersfoort, J., F.H Schaftenaar, H. Douna, P.J van Santbrink, M.J Kröner, G.H.M van Puijvelde, P.H.A Quax, J. Kuiper, and I. Bot. "Lipocalin-2 Contributes to Experimental Atherosclerosis in a Stage-dependent Manner." Atherosclerosis (00219150) 275 (2018): 214. https://doi.org/10.1016/j.atherosclerosis.2018.06.015.

MLA (9th ed.) Citation

Amersfoort, J., et al. "Lipocalin-2 Contributes to Experimental Atherosclerosis in a Stage-dependent Manner." Atherosclerosis (00219150), vol. 275, 2018, p. 214, https://doi.org/10.1016/j.atherosclerosis.2018.06.015.